TCIM
IDXX icon

TIAA CREF Investment Management’s Idexx Laboratories IDXX Stock Holding History

TIAA CREF Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$81.1M Buy
362,595
+35,906
+11% +$7.41M 0.06% 297
2018
Q4 		$60.8M Buy
326,689
+36,371
+13% +$7.46M 0.05% 346
2018
Q3 		$72.5M Sell
290,318
-98,283
-25% -$23.9M 0.05% 340
2018
Q2 		$84.7M Buy
388,601
+72,499
+23% +$14.9M 0.06% 311
2018
Q1 		$60.5M Sell
316,102
-111,038
-26% -$20.5M 0.04% 390
2017
Q4 		$66.8M Sell
427,140
-73,302
-15% -$11.5M 0.04% 376
2017
Q3 		$77.8M Sell
500,442
-17,946
-3% -$2.84M 0.05% 335
2017
Q2 		$83.7M Buy
518,388
+128,297
+33% +$20.8M 0.06% 319
2017
Q1 		$60.3M Sell
390,091
-57,614
-13% -$7.94M 0.04% 406
2016
Q4 		$52.5M Buy
447,705
+50,417
+13% +$5.75M 0.04% 418
2016
Q3 		$44.8K Buy
397,288
+64,406
+19% +$6.79M 0.03% 476
2016
Q2 		$30.9M Buy
332,882
+9,357
+3% +$804K 0.02% 575
2016
Q1 		$25.3M Sell
323,525
-154,648
-32% -$11.1M 0.02% 655
2015
Q4 		$34.9M Sell
478,173
-329,170
-41% -$23.5M 0.03% 570
2015
Q3 		$59.9M Sell
807,343
-1,404
-0.2% -$101K 0.05% 390
2015
Q2 		$51.9M Sell
808,747
-343,003
-30% -$23.7M 0.04% 469
2015
Q1 		$89M Buy
1,151,750
+652,140
+131% +$50.7M 0.06% 331
2014
Q4 		$37M Sell
499,610
-38,602
-7% -$2.71M 0.03% 563
2014
Q3 		$31.7M Buy
538,212
+7,886
+1% +$499K 0.02% 609
2014
Q2 		$35.4M Sell
530,326
-131,776
-20% -$8.38M 0.02% 595
2014
Q1 		$40.2M Buy
662,102
+25,272
+4% +$1.51M 0.03% 549
2013
Q4 		$33.9M Buy
636,830
+41,432
+7% +$2.18M 0.02% 608
2013
Q3 		$29.7M Sell
595,398
-138,318
-19% -$6.65M 0.02% 619
2013
Q2 		$32.9M Buy
+733,716
New +$32.1M 0.03% 563

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TIAA CREF Investment Management's IDXX Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Idexx Laboratories (IDXX) stake by 11% in Q1 2019, buying an estimated $7.41M and bringing the position to 362,595 shares worth $81.1M. The position accounts for 0.06% of the portfolio, ranked #297.

TIAA CREF Investment Management first reported a position in IDXX in Q2 2013 and has held it in 24 quarters since. The position peaked at $89M in Q1 2015. 684 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

  • TIAA CREF Investment Management held 362,595 shares of Idexx Laboratories worth $81.1M as of Q1 2019.
  • TIAA CREF Investment Management bought 35,906 Idexx Laboratories shares in Q1 2019, an estimated $7.41M.
  • Idexx Laboratories made up 0.06% of TIAA CREF Investment Management's portfolio in Q1 2019, its #297 holding.
  • TIAA CREF Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Idexx Laboratories position peaked at $89M in Q1 2015.
  • 684 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.